Cat. No. | Product name | CAS No. |
DC8171 |
Decernotinib (VX-509,adelatinib)
Featured
Decernotinib(VX-509; VRT-831509) is a potent and selective Janus kinase 3 (JAK3) inhibitor with Ki of 2.5 nM; IC50 is 50-170 nM in cellular assays. |
944842-54-0 |
DC7695 |
Defactinib (VS-6063, PF-04554878)
Featured
Defactinib is a potent, selective, and orally active FAK inhibitor with demonstrated tolerability and preliminary clinical activity working as a single agent as well as in combination with paclitaxel. |
1073154-85-4 |
DC10100 |
Defactinib hydrochloride
Featured
Defactinib is a potent, selective, and orally active FAK inhibitor with demonstrated tolerability and preliminary clinical activity working as a single agent as well as in combination with paclitaxel. |
1073160-26-5 |
DCAPI1107 |
Deferasirox (Exjade)
Featured
Deferasirox (Exjade) |
201530-41-8 |
DC8481 |
Delanzomib(CEP-18770)
Featured
Delanzomib(CEP-18770) is a novel orally-active inhibitor of the chymotrypsin-like activity of the proteasome that down-modulates the nuclear factor-kappaB (NF-kappaB) activity. |
847499-27-8 |
DC11352 |
Delavirdine (mesylate)
Delavirdine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that selectively inhibits HIV-1 reverse transcriptase over DNA polymerase α and δ in vitro (IC50s = 0.26, 440, and >550 μM, respectively). |
147221-93-0 |
DC8897 |
Delavirdine
Delavirdine(U 90152) is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI). |
136817-59-9 |
DC11890 |
Delgocitinib
Featured
Delgocitinib (JTE-052, LEO 124249) is a potent, selective, orally active, pan-JAK inhibitor with IC50 of 2.8, 2.6, 13 and 58 nM for JAK1,2,3 and Tyk2, respectively. |
1263774-59-9 |
DC10612 |
Delpazolid (LCB01-0371)
Featured
Delpazolid (LCB01-0371) is a new oxazolidinone with cyclic amidrazone. |
1219707-39-7 |
DC10559 |
Derazantinib (ARQ 087)
Featured
Derazantinib (Derazantinib) is an ATP competitive tyrosine kinase inhibitor; exhibits potent activity against FGFR1-3 chondrocytes with IC50s of 4.5, 1.8, and 4.5 nM, respectively. |
1234356-69-4 |
DC9604 |
Desogestrel
Featured
Desogestrel(Org-2969) is a third-generation 19-nortestosterone derivative progestogen; is contained in many oral contraceptive preparations, both combined (COCs) to ethinyl-estradiol (EE) or alone in a progestin-only pill (POP). |
54024-22-5 |
DCAPI1475 |
Dexrazoxane Hydrochloride
Dexrazoxane Hydrochloride |
149003-01-0 |
DC9414 |
DGAT-1 inhibitor 2
DGAT-1 inhibitor 2 is an effective inhibitor of DGAT-1;antiobesity agents. |
942999-61-3 |
DC9551 |
Difluprednate
Featured
Difluprednate(Durezol) is a corticosteroid, approved difluprednate for the treatment of post-operative ocular inflammation and pain. |
23674-86-4 |
DCAPI1152 |
Diltiazem HCl (Tiazac)
Diltiazem HCl (Tiazac) |
33286-22-5 |
DC10446 |
(3R,4S,5S)-tert-butyl 3-Methoxy-5-Methyl-4-(MethylaMino)heptanoate hydroc hloride
Featured
Diltiazem hydrochloride is a calcium ion influx inhibitor (slow channel blocker or calcium antagonist). |
120205-48-3 |
DC7114 |
Dinaciclib (SCH727965)
Featured
Dinaciclib (SCH727965) is a novel and potent CDK inhibitor for CDK2, CDK5, CDK1 and CDK9 with IC50 of 1 nM, 1 nM, 3 nM and 4 nM, respectively. |
779353-01-4 |
DC9434 |
DMP 777
DMP 777(L-694458) is a potent, selective, and orally active human leukocyte elastase (HLE) inhibitor. |
157341-41-8 |
DC9588 |
Dofequidar (fumarate)
Dofequidar fumarate(MS-209 fumarate), an orally active quinoline compound, has been reported to overcome MDR by inhibiting ABCB1/P-gp, ABCC1/MDR-associated protein 1, or both. |
153653-30-6 |
DC7273 |
Dolutegravir
Featured
Dolutegravir (DTG, GSK1349572) is an integrase inhibitor(IC50= 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H. |
1051375-16-6 |
DC10250 |
Dolutegravir Sodium
Featured
Dolutegravir is a HIV integrase inhibitor with IC50 of 2.7 nM. |
1051375-19-9 |
DC11103 |
Tavapadon
Featured
Tavapadon is a potent, orally-bioavailable, selective partial agonist of the dopamine D1 and D5 receptors. |
1643489-24-0 |